Atossa Genetics Inc (NASDAQ:ATOS) – Equities research analysts at Zacks Investment Research increased their FY2016 earnings per share (EPS) estimates for shares of Atossa Genetics in a research note issued to investors on Wednesday, Zacks Investment Research reports. Zacks Investment Research analyst G. Zeng now anticipates that the brokerage will post earnings per share of […]
